{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:55:19Z","timestamp":1791424519369,"version":"4.3.3"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.clinthera.2007.10.008","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T21:27:33Z","timestamp":1196112453000},"page":"2215-2221","source":"Crossref","is-referenced-by-count":22,"title":["Identification and Pretherapy Susceptibility of Pathogens in Patients with Complicated Urinary Tract Infection or Acute Pyelonephritis Enrolled in a Clinical Study in the United States from November 2004 Through April 2006"],"prefix":"10.1016","volume":"29","author":[{"given":"Janet","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simrati","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Khashab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.10.008_bib1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1198-743x.2001.00326.x","article-title":"Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study)","volume":"7","author":"Bouza","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2007.10.008_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0732-8893(01)00254-1","article-title":"Epidemiology andfrequency of resistance among pathogens causing urinary tract infections in 1510 hospitalized patients: A report from the SENTRY Antimicrobial Surveillance Program (North America)","volume":"40","author":"Mathai","year":"2001","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.clinthera.2007.10.008_bib3","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1469-0691.2006.01398.x","article-title":"Current challenges in the treatment of complicated urinary tract infections and prostatitis","volume":"12","author":"Wagenlehner","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.clinthera.2007.10.008_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1086\/320880","article-title":"Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis","volume":"33","author":"Gupta","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2007.10.008_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.ijantimicag.2005.08.003","article-title":"Antibiotic resistance in outpatient urinary isolates: Final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)","volume":"26","author":"Zhanel","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2007.10.008_bib6","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0011-5029(03)90003-4","article-title":"Addressing antibiotic resistance","volume":"49","author":"Gupta","year":"2003","journal-title":"Dis Mon"},{"key":"10.1016\/j.clinthera.2007.10.008_bib7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.281.8.736","article-title":"Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women","volume":"281","author":"Gupta","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2007.10.008_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ijantimicag.2006.02.009","article-title":"Antibiotic resistance in Escherichia coli outpatient urinary isolates: Final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA)","volume":"27","author":"Zhanel","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2007.10.008_bib9","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jama.283.12.1583","article-title":"Comparison of ciprofloxacin (7 days) and trimethoprimsulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial","volume":"283","author":"Talan","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2007.10.008_bib10","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1128\/AAC.38.6.1368","article-title":"Treatment of complicated urinary tract infections with lomefloxacin compared with that with trimethoprim-sulfamethoxazole","volume":"38","author":"Nicolle","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2007.10.008_bib11","unstructured":"Peterson J, Kaul S, Khashab M, et al. A double-blind, randomized comparison of levofloxacin 750 mg oncedaily for five days to ciprofloxacin 400\/500 mg twice daily for 10 days in the treatment of complicated urinary tract infections and acute pyelonephritis. Urology. In press."},{"key":"10.1016\/j.clinthera.2007.10.008_bib12","unstructured":"World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [WMA Web site]. Adopted by the 18th WMA General Assembly, Helsinki, Finland, June 1964, and amended by the 52nd WMA General Assembly, Edinburgh, Scotland, October 2000. http:\/\/www.wma.net\/e\/policy\/b3.htm. Accessed November 15, 2006."},{"key":"10.1016\/j.clinthera.2007.10.008_bib13","unstructured":"European Agency for the Evaluation of Medicinal Products, International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6. Geneva, Switzerland: WHO; 2002. http:\/\/www.emea.eu.int. Accessed August 2007."},{"key":"10.1016\/j.clinthera.2007.10.008_bib14","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicriobial susceptibility testing: M100-S15. January 2005."},{"key":"10.1016\/j.clinthera.2007.10.008_bib15","series-title":"Statistical Method for Rates and Proportions","first-page":"381","author":"Fleiss","year":"2003"},{"key":"10.1016\/j.clinthera.2007.10.008_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0011-5029(03)90001-0","article-title":"The etiology of urinary tract infection: Traditional and emerging pathogens","volume":"49","author":"Ronald","year":"2003","journal-title":"Dis Mon"},{"key":"10.1016\/j.clinthera.2007.10.008_bib17","series-title":"Ortho-McNeil Pharmaceutical I Trust 10 2006","year":"2006"},{"key":"10.1016\/j.clinthera.2007.10.008_bib18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11883-004-0050-5","article-title":"Low-density lipoprotein particle number and risk for cardiovascular disease","volume":"6","author":"Cromwell","year":"2004","journal-title":"Curr Atheroscler Rep"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2007.10.008_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0924-8579(03)00229-2","article-title":"The ECO.SENS study","volume":"22","author":"Kahlmeter","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2007.10.008_bib20","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ijantimicag.2006.07.026","article-title":"Concentrations in plasma, urinary excretion and bactericidal activity of levofloxacin (500 mg) versus ciprofloxacin (500 mg) in healthy volunteers receiving a single oral dose","volume":"28","author":"Wagenlehner","year":"2006","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2007.10.008_bib21","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.ijantimicag.2003.09.002","article-title":"Gatifloxacin 200 mg or 400 mg once daily is as effective as ciprofloxacin 500 mg twice daily for the treatment of patients with acute pyelonephritis or complicated urinary tract infections","volume":"23","author":"Naber","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.clinthera.2007.10.008_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0090-4295(98)00160-5","article-title":"Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis","volume":"52","author":"Richard","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.clinthera.2007.10.008_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijantimicag.2006.11.021","article-title":"Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?","volume":"29","author":"Miller","year":"2007","journal-title":"Int J Antimicrob Agents"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807003323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807003323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T19:56:16Z","timestamp":1546458976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807003323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0149291807003323"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.10.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}